Hopp til hovedinnhold
Toggle navigation
Live markets
Search
Search
Search
Search
My profile
My Subscriptions
Watchlists
Quote alerts
Create account
Sign in
NB
FR
EN
PT
NL
NB
DE
IT
Hjem
Company Press Releases
Company press releases
Abonner
Filtre
Filtre
Oppdater
Nullstill
Icon After
Dato
Toggle Visibility
Alle
I dag
Denne uken
Denne måneden
Tilpasset datosøk
Fra
Til
Kategori
Toggle Visibility
Alliances and agreements
Annen informasjonspliktig regulatorisk informasjon
Change in Capital
Commercial operations
Commercial results
Corporate life
Dividend
Eks.dato
Endringer i rettighetene til aksjer / verdipapirer
Flagging
General meeting / Board Meeting
Halvårsrapporter og revisjonsberetninger / uttalelser om forenklet revisorkontroll
Ikke-informasjonspliktige pressemeldinger
Income
Innsideinformasjon
Joint venture
Journal / appointments
Kapital- og stemmerettsendringer
Legal
Meetings / events
Meldepliktig handel for primærinnsidere
Mergers, Acquiqitions, Transferts
New
New establishment
News contracts
Other financial transaction
Other subject
Polls / Surveys
Products and services
Prospekt / opptaksdokument
Rapportering om betaling til myndigheter (land-for-land rapportering)
Rating
Renteregulering
Sales
Share history
Share introduction and issues
Takeover bids
Trends / Analyses
Utsteders meldeplikt ved handel i egne aksjer
Valg av hjemstat
Årsrapporter og revisjonsberetninger
Leverandør
Toggle Visibility
ActusNewsWire
BusinessWire
EQS Group
Euronext
GlobeNewswire
Les Echos
Marketwire
Modular Finance
Oslo Børs Newspoint
PR Newswire
Viser 1 - 50 av 140 resultater
Tid
Selskap
Tittel
Sektor
Kategori
16 May 2024
18:30 CEST
POXEL
Poxel Reports Revenue for the First Quarter 2024 and Provides Corporate Update
20103010 Biotechnology
Sales
16 May 2024
18:30 CEST
POXEL
Poxel publie son chiffre d’affaires pour le premier trimestre 2024 et dresse un bilan de ses activités
20103010 Biotechnology
Sales
29 Apr 2024
18:00 CEST
POXEL
Poxel Provides a Financial Update for the First Quarter 2024 and Announces the Postponement of its 2023 Full-Year Results Release
20103010 Biotechnology
Other subject
29 Apr 2024
18:00 CEST
POXEL
Poxel fait le point sur sa situation financière au premier trimestre 2024 et annonce le report de la publication de ses résultats annuels 2023
20103010 Biotechnology
Other subject
28 Mar 2024
19:24 CET
POXEL
Poxel to Report Its 2023 Annual Results by the End of April 2024
20103010 Biotechnology
Other subject
28 Mar 2024
19:24 CET
POXEL
Poxel publiera ses résultats annuels 2023 d'ici fin avril 2024
20103010 Biotechnology
Other subject
15 Feb 2024
18:10 CET
POXEL
Poxel Reports Cash and Revenue for the Full Year 2023 and Provides Corporate Update
20103010 Biotechnology
Sales
15 Feb 2024
18:10 CET
POXEL
Poxel publie sa trésorerie et son chiffre d'affaires pour l'ensemble de l'année 2023 et dresse un bilan de ses activités
20103010 Biotechnology
Sales
11 Jan 2024
18:00 CET
POXEL
Poxel : nombre d’actions et de droits de vote composant le capital social
20103010 Biotechnology
Share history
08 Jan 2024
18:00 CET
POXEL
POXEL : Bilan semestriel du contrat de liquidité contracté avec ODDO BHF SCA
20103010 Biotechnology
Legal
03 Jan 2024
18:00 CET
POXEL
Poxel Announces its Financial Calendar for 2024
20103010 Biotechnology
Other subject
03 Jan 2024
18:00 CET
POXEL
Poxel annonce son agenda financier 2024
20103010 Biotechnology
Other subject
21 Dec 2023
18:15 CET
POXEL
Poxel fait un point sur ses activités
20103010 Biotechnology
Other subject
21 Dec 2023
18:15 CET
POXEL
Poxel Provides Corporate Update
20103010 Biotechnology
Other subject
05 Dec 2023
18:00 CET
POXEL
Poxel : nombre d’actions et de droits de vote composant le capital social
20103010 Biotechnology
Other subject
08 Nov 2023
18:12 CET
POXEL
Poxel Provides Corporate Update and Reports Cash and Revenue for the Third Quarter and Nine Months 2023
20103010 Biotechnology
Sales
08 Nov 2023
18:12 CET
POXEL
Poxel dresse un bilan de ses activités et publie sa trésorerie et son chiffre d’affaires pour le troisième trimestre et les neuf premiers mois de 2023
20103010 Biotechnology
Sales
07 Nov 2023
17:45 CET
POXEL
Poxel : nombre d’actions et de droits de vote composant le capital social
20103010 Biotechnology
Share history
12 Oct 2023
07:30 CEST
POXEL
Poxel annonce sa participation prochaine à deux conférences investisseurs
20103010 Biotechnology
Other subject
12 Oct 2023
07:30 CEST
POXEL
Poxel Announces its Participation at Upcoming Investor Conferences
20103010 Biotechnology
Other subject
03 Oct 2023
17:45 CEST
POXEL
Poxel : nombre d’actions et de droits de vote composant le capital social
20103010 Biotechnology
Legal
02 Oct 2023
17:45 CEST
POXEL
Poxel Announces its Participation at Upcoming Scientific Conference
20103010 Biotechnology
Other subject
02 Oct 2023
17:45 CEST
POXEL
Poxel annonce sa participation prochaine à une conférence scientifique
20103010 Biotechnology
Other subject
26 Sep 2023
07:30 CEST
POXEL
Poxel Reports Financial Results for First Half 2023 and Provides a Corporate Update
20103010 Biotechnology
Sales
26 Sep 2023
07:30 CEST
POXEL
Poxel publie ses résultats financiers pour le premier semestre 2023 et dresse un bilan de ses activités
20103010 Biotechnology
Sales
07 Sep 2023
07:30 CEST
POXEL
Poxel présentera ses résultats semestriels 2023 à l’occasion d’une vidéo-conférence le 26 septembre 2023
20103010 Biotechnology
Other subject
07 Sep 2023
07:30 CEST
POXEL
Poxel to Report 2023 First Half-Year Results and host a video conference on September 26, 2023
20103010 Biotechnology
Other subject
05 Sep 2023
17:45 CEST
POXEL
Poxel : nombre d’actions et de droits de vote composant le capital social
20103010 Biotechnology
Share history
30 Aug 2023
17:45 CEST
POXEL
Poxel Reports Cash and Revenue for the Second Quarter and First Half 2023 and Provides Corporate Update
20103010 Biotechnology
Sales
30 Aug 2023
17:45 CEST
POXEL
Poxel publie sa trésorerie et son chiffre d'affaires pour le deuxième trimestre et le premier semestre 2023 et dresse un bilan de ses activités
20103010 Biotechnology
Sales
04 Aug 2023
18:00 CEST
POXEL
Poxel : nombre d’actions et de droits de vote composant le capital social
20103010 Biotechnology
Legal
18 Jul 2023
08:06 CEST
POXEL
Poxel Announces Upcoming Participation at the H.C. Wainwright 2nd Annual Kidney Conference
20103010 Biotechnology
Other subject
18 Jul 2023
08:06 CEST
POXEL
Poxel annonce sa participation prochaine à la 2ème conférence annuelle H.C. Wainwright sur les Maladies Rénales
20103010 Biotechnology
Other subject
12 Jul 2023
18:00 CEST
POXEL
POXEL SA : Bilan semestriel du contrat de liquidité contracté avec ODDO BHF SCA
20103010 Biotechnology
Legal
05 Jul 2023
17:45 CEST
POXEL
Poxel, lauréat de l’édition 2023 du concours I-nov
20103010 Biotechnology
New
05 Jul 2023
17:45 CEST
POXEL
Poxel, winner of the 2023 edition of the I-nov contest
20103010 Biotechnology
New
04 Jul 2023
18:00 CEST
POXEL
Poxel : nombre d’actions et de droits de vote composant le capital social
20103010 Biotechnology
Share history
30 Jun 2023
07:30 CEST
POXEL
Poxel Announces the Approval of a Prospectus for the Listing of New Shares on Euronext Paris
20103010 Biotechnology
Legal
30 Jun 2023
07:30 CEST
POXEL
Poxel annonce l’approbation d’un prospectus pour l’admission d’actions nouvelles sur Euronext Paris
20103010 Biotechnology
Legal
23 Jun 2023
17:45 CEST
POXEL
Poxel annonce les résultats de son Assemblée générale ordinaire annuelle et extraordinaire du 21 juin 2023
20103010 Biotechnology
General meeting / Board Meeting
23 Jun 2023
17:45 CEST
POXEL
Poxel Announces Results from June 21, 2023 Ordinary Annual and Extraordinary General Meeting
20103010 Biotechnology
General meeting / Board Meeting
15 Jun 2023
07:30 CEST
POXEL
Poxel annonce sa participation à des conférences organisées par des associations de patients dans le domaine de l'adrénoleucodystrophie
20103010 Biotechnology
Other subject
15 Jun 2023
07:30 CEST
POXEL
Poxel Announces its Participation at Patient Association Conferences in Adrenoleukodystrophy
20103010 Biotechnology
Other subject
02 Jun 2023
17:45 CEST
POXEL
Poxel : nombre d’actions et de droits de vote composant le capital social
20103010 Biotechnology
Other subject
17 May 2023
17:45 CEST
POXEL
Poxel Reports Cash and Revenue for the First Quarter 2023 and Provides Corporate Update
20103010 Biotechnology
Sales
17 May 2023
17:45 CEST
POXEL
Poxel publie sa trésorerie et son chiffre d'affaires pour le premier trimestre 2023 et dresse un bilan de ses activités
20103010 Biotechnology
Sales
16 May 2023
07:30 CEST
POXEL
Poxel Announces Notice of Its Annual General Meeting to Be Held on June 21, 2023
20103010 Biotechnology
General meeting / Board Meeting
16 May 2023
07:30 CEST
POXEL
Poxel annonce la publication de l’avis de réunion de son Assemblée Générale qui se tiendra le 21 juin 2023
20103010 Biotechnology
General meeting / Board Meeting
15 May 2023
17:45 CEST
POXEL
Poxel Announces TWYMEEG® (Imeglimin) Fiscal Year 2022 Sales
20103010 Biotechnology
Other subject
15 May 2023
17:45 CEST
POXEL
Poxel annonce les ventes de TWYMEEG® (Imeglimine) pour l'exercice 2022
20103010 Biotechnology
Other subject
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Press release
Open in new window
Sider
1
2
3
›
››
»
Last »
Company press releases subscription
×
To subscribe to Press releases from this issuer, visit the Subscription to Company news section in
Hjem
Markeder
Amsterdam
Cash Products
Aksjer
AEX index Stocks
AEX ESG Stocks
Indekser
Fond
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksopsjoner
Indeksfutures
Aksjeopsjoner
Utbyttederivater
Aksjefutures
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Brussel
Cash products
Aksjer
Euronext regulated
Euronext Growth
Euronext Access
Expert Market
BEL 20 Stocks
Indekser
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksfutures
Aksjeopsjoner
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Expert Market
Dublin
Stocks
Euronext regulated
Euronext Growth
ISEQ 20 Stocks
Indices
Funds
Bonds
Irish Government Bonds
DOL
Lisboa
Cash Products
Aksjer
Euronext regulated
Euronext Access
PSI Stocks
Indekser
Obligasjoner
Derivater
Indeksfutures
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Milan
Cash Products
Stocks
Euronext Milan
Euronext Growth Milan
Euronext Star Milan
Euronext Global Equity Market
EuroTLX
Trading After Hours
MIB ESG Stocks
Bonds
MOT
Euronext Access Milan
EuroTLX
Structured Products
SeDeX
EuroTLX
ETFs
Funds
Derivative products
All derivatives
Index futures
Index options
Stock options
Stock futures
Dividend derivatives
Quote Vendor Codes
IPOs
Oslo
Aksjer, renter, indekser
Aksjer
Oslo Børs
Euronext Growth
Euronext Expand
Top performers
OBX aksjer
OBX ESG aksjer
OSEBX aksjer
OSEFX Aksjer
Seafood Aksjer
Shipping Aksjer
Aksjeindekser
Obligasjoner
Oslo Børs
Nordic Alternative Bond Market
Obligasjonsindekser
ETFer
Fond
Derivater
Derivative products
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Finanskalender
Primærinnsidere
Paris
Cash Products
Aksjer
Euronext regulated
Euronext Growth
Euronext Access
CAC 40 Stocks
CAC 40 ESG Stocks
Indekser
Obligasjoner
ETF-er
Strukturerte produkter
Derivater
Indeksfutures
Indeksopsjoner
Aksjeopsjoner
Aksjefutures
Utbyttederivater
Quote Vendor Codes
Selskapsmeldinger
Latest
Archive
Aksjer
All Markets directories
All Markets
Euronext regulated
Euronext Growth
Euronext Access
Euronext Expand
Euronext Global Equity Market
EuroTLX
Trading After Hours
Selskapsmeldinger
Latest
Archive
Nye aksjenoteringer
Alle aksjenoteringer
Euronext Growth advisors
Euronext Tech Leaders
Family business
Indekser
Directory
Grønne indekser
Indices documents
Indices news
Indekser høringer
Kontakter Euronext-indekser
ETF-er
Directory
Grønne ETF-er
Fond
Directory
ESG Funds
Oslo Mutual Funds
Obligasjoner
Grønne obligasjoner
1.5° Bonds
All Markets directories
All Markets
Amsterdam
Brussels
Dublin
Lisbon
Oslo
Milan
Paris
Strukturerte produkter
Directory / search
Bid-Only trading status
Trading Turbos in the Netherlands
Derivater
Indeksfutures
Indeksopsjoner
Aksjeopsjoner
Aksjefutures
Utbyttederivater
ETF opsjoner
Kontraktsspesifikasjoner
Tick sizes
Rapportering av handler
Leverandørkoder markedsdata
Råvarer
Quotes
Quotes snapshot
Milling Wheat futures
Rapeseed futures
Corn futures
European Durum Wheat Futures
Milling Wheat options
Rapeseed options
Corn options
Bortfallskalendre
Bortfall
Wholesale Trading
Commitments of Traders (CoT) report
Kontraktsspesifikasjoner
Leverandørkoder markedsdata
Knowledge Centre
Bid & Ask
Options Investing E-learning
Contract Specifications
Position Management
Intrinsic Value
Premium & Valuation
Moneyness
Positions
Euronext News
Ressurser
Statistikk & rapporter
Quality of execution
Åpningstider
Kontraktsspesifikasjoner
Leverandørkoder markedsdata
Key Information Document
Class level
Product group level
Notices / Corporate actions
Cash Notices / Corporate actions
Derivatives corporate actions
All Corporate Actions
Latest
Unusual Contract Sizes, Dividends
Corporate Action Services
Corporate Action Policies
Derivatives notices
Markedshendelser
Suspenderte instrumenter
Stressed Market Conditions
Brudd på Double Cap limits
Ekstraordinære markedsforhold
Diverse meldinger
Market status
Medlemsliste
Issuers compliance
Hvor du finner hva